#

Novo Nordisk

: 109
Investors are waiting for the FOMC member to assess inflationary processes and their impact on economic growth / Photo: Stockinasia / Shutterstock
News·
Morning in New York: Statistics and Fed rhetoric will set the tone for trading
Novo Nordisk shares rise after rival company says it will stop selling Wegovy analog in the U.S. / Photo: Photo Nature Travel / Shutterstock
News·
Novo shares rise: cheap copy of its drug fails to survive criticism from US regulator
Photo: X/NYSE
News·
Morning in New York: waiting for the sentiment to stabilize
Novo Nordisk shares fell after Him&Hers announced the launch of its weight loss pill/ Photo: x.com/novonordisk
News·
Novo Nordisk and Eli Lilly shares plummet: the weight-loss pill will have a $49 copy
Eli Lilly forecasts revenue growth of 23-27% in 2026 / Photo: Tada Images/Shutterstock.com
News·
Eli Lilly predicted revenue growth of 27% in 2026. Why is it better than Novo Nordisk?
Investors remain focused on the personnel reshuffle in the Feds leadership and its impact on guidance on the course of monetary policy / Photo: Shutterstock.com/Kirkam
News·
Morning in New York: investors in search of a foothold
Novos revenue could fall 5-13% in 2026/ Photo: Kittyfly/ Shutterstock.com
News·
Novo Nordisk warned of a drop in revenue in 2026. Quotes collapsed by 15%
Alphabet, Googles parent company, will release its quarterly report this week / Photo: Shutterstock.com
News·
Google and Amazon earnings, US employment: what investors need to know this week
A generic price war could drop the cost of semaglutide in some countries to $15 for a monthly course / Photo: charlesdeluvio / Unsplash.com
Review·
Substance-for-money exchange: $32 billion semaglutide market enters patent collapse phase
Half of weight loss drug users dream of going to the gym, Stifel has found / Photo: Jonathan Weiss / Shutterstock.com
News·
Stifel expects fitness chain's stock to rise 30%. How will a diet pill help them?
Airlines will receive bonuses from slimming passengers / Photo: mikeledray / Shutterstock.com
News·
Jefferies names unexpected beneficiaries of the popularity of weight-loss drugs
New York morning: pressure on Powell triggers selloffs
News·
New York morning: pressure on Powell triggers selloffs
Load more